Helicobacter pylori is an organism that is thought to be important in the pathophysiology of ulcer disease and gastritis.
Eradication of the organism is useful in the treatment of infected patients. Efficacious regimens generally include
an antisecretory agent combined with two antimicrobials. The main determinant of the overall cost of treatment is
the eradication of H. pylori in the microorganism. Resistance to the commonly used antibiotics can occur but it can
be usually overcome with regimen changes. It is important for care physicians to clearly understand when and how
to test and how to select appropriate therapy for Helicobacter pylori infection.
Helicobacter pylori, ulcer disease of stomach and duodenum, Maastricht Consensus Report 1996,